Abdulreda, Midhat H.
Molano, R. Damaris
Faleo, Gaetano
Lopez-Cabezas, Maite
Shishido, Alexander
Ulissi, Ulisse
Fotino, Carmen
Hernandez, Luis F.
Tschiggfrie, Ashley
Aldrich, Virginia R.
Tamayo-Garcia, Alejandro
Bayer, Allison S.
Ricordi, Camillo
Caicedo, Alejandro
Buchwald, Peter
Pileggi, Antonello
Berggren, Per-Olof
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U19AI050864)
Juvenile Diabetes Research Foundation International (4-2008-811)
National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK116241/K01DK097194/F32DK083226)
Article History
Received: 14 January 2019
Accepted: 22 March 2019
First Online: 14 May 2019
Change Date: 12 June 2019
Change Type: Correction
Change Details: Unfortunately there is a mistake in the presentation of the affiliations in this paper.
Duality of interest
: P-OB is cofounder and CEO of Biocrine, an unlisted biotech company that is using the ACE technique as a research tool. MHA is consultant for the same company. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.